164 related articles for article (PubMed ID: 17400919)
1. Structural factors affecting the choice between latency transition and polymerization in inhibitory serpins.
Yi JY; Im H
Protein Sci; 2007 May; 16(5):833-41. PubMed ID: 17400919
[TBL] [Abstract][Full Text] [Related]
2. Specific interactions of serpins in their native forms attenuate their conformational transitions.
Na YR; Im H
Protein Sci; 2007 Aug; 16(8):1659-66. PubMed ID: 17600149
[TBL] [Abstract][Full Text] [Related]
3. Probing the local conformational change of alpha1-antitrypsin.
Baek JH; Im H; Kang UB; Seong KM; Lee C; Kim J; Yu MH
Protein Sci; 2007 Sep; 16(9):1842-50. PubMed ID: 17660256
[TBL] [Abstract][Full Text] [Related]
4. The length of the reactive center loop modulates the latency transition of plasminogen activator inhibitor-1.
Na YR; Im H
Protein Sci; 2005 Jan; 14(1):55-63. PubMed ID: 15576554
[TBL] [Abstract][Full Text] [Related]
5. Structural basis for serpin inhibitor activity.
Wright HT; Scarsdale JN
Proteins; 1995 Jul; 22(3):210-25. PubMed ID: 7479695
[TBL] [Abstract][Full Text] [Related]
6. Engineering of conformations of plasminogen activator inhibitor-1. A crucial role of beta-strand 5A residues in the transition of active form to latent and substrate forms.
Kirkegaard T; Jensen S; Schousboe SL; Petersen HH; Egelund R; Andreasen PA; Rodenburg KW
Eur J Biochem; 1999 Jul; 263(2):577-86. PubMed ID: 10406969
[TBL] [Abstract][Full Text] [Related]
7. Preparative induction and characterization of L-antithrombin: a structural homologue of latent plasminogen activator inhibitor-1.
Wardell MR; Chang WS; Bruce D; Skinner R; Lesk AM; Carrell RW
Biochemistry; 1997 Oct; 36(42):13133-42. PubMed ID: 9335576
[TBL] [Abstract][Full Text] [Related]
8. Identification of positively charged residues contributing to the stability of plasminogen activator inhibitor 1.
Gils A; Lu J; Aertgeerts K; Knockaert I; Declerck PJ
FEBS Lett; 1997 Sep; 415(2):192-5. PubMed ID: 9350994
[TBL] [Abstract][Full Text] [Related]
9. Importance of the amino-acid composition of the shutter region of plasminogen activator inhibitor-1 for its transitions to latent and substrate forms.
Hansen M; Busse MN; Andreasen PA
Eur J Biochem; 2001 Dec; 268(23):6274-83. PubMed ID: 11733024
[TBL] [Abstract][Full Text] [Related]
10. Mutational analysis of plasminogen activator inhibitor-1.
Wind T; Jensen JK; Dupont DM; Kulig P; Andreasen PA
Eur J Biochem; 2003 Apr; 270(8):1680-8. PubMed ID: 12694181
[TBL] [Abstract][Full Text] [Related]
11. Interactions causing the kinetic trap in serpin protein folding.
Im H; Woo MS; Hwang KY; Yu MH
J Biol Chem; 2002 Nov; 277(48):46347-54. PubMed ID: 12244055
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen activator inhibitor 1. Structure of the native serpin, comparison to its other conformers and implications for serpin inactivation.
Nar H; Bauer M; Stassen JM; Lang D; Gils A; Declerck PJ
J Mol Biol; 2000 Mar; 297(3):683-95. PubMed ID: 10731421
[TBL] [Abstract][Full Text] [Related]
13. The active conformation of plasminogen activator inhibitor 1, a target for drugs to control fibrinolysis and cell adhesion.
Sharp AM; Stein PE; Pannu NS; Carrell RW; Berkenpas MB; Ginsburg D; Lawrence DA; Read RJ
Structure; 1999 Feb; 7(2):111-8. PubMed ID: 10368279
[TBL] [Abstract][Full Text] [Related]
14. VLHL plasminogen activator inhibitor spontaneously reactivates from the latent to active form.
Jankun J; Aleem AM; Selman SH; Basrur V; Skrzypczak-Jankun E
Int J Mol Med; 2009 Jan; 23(1):57-63. PubMed ID: 19082507
[TBL] [Abstract][Full Text] [Related]
15. Interfering with the inhibitory mechanism of serpins: crystal structure of a complex formed between cleaved plasminogen activator inhibitor type 1 and a reactive-centre loop peptide.
Xue Y; Björquist P; Inghardt T; Linschoten M; Musil D; Sjölin L; Deinum J
Structure; 1998 May; 6(5):627-36. PubMed ID: 9634700
[TBL] [Abstract][Full Text] [Related]
16. Different structural requirements for plasminogen activator inhibitor 1 (PAI-1) during latency transition and proteinase inhibition as evidenced by phage-displayed hypermutated PAI-1 libraries.
Stoop AA; Eldering E; Dafforn TR; Read RJ; Pannekoek H
J Mol Biol; 2001 Jan; 305(4):773-83. PubMed ID: 11162091
[TBL] [Abstract][Full Text] [Related]
17. Conformational changes of the reactive-centre loop and beta-strand 5A accompany temperature-dependent inhibitor-substrate transition of plasminogen-activator inhibitor 1.
Kjøller L; Martensen PM; Sottrup-Jensen L; Justesen J; Rodenburg KW; Andreasen PA
Eur J Biochem; 1996 Oct; 241(1):38-46. PubMed ID: 8898886
[TBL] [Abstract][Full Text] [Related]
18. Preparation and characterization of latent alpha 1-antitrypsin.
Lomas DA; Elliott PR; Chang WS; Wardell MR; Carrell RW
J Biol Chem; 1995 Mar; 270(10):5282-8. PubMed ID: 7890640
[TBL] [Abstract][Full Text] [Related]
19. Latency transition of plasminogen activator inhibitor type 1 is evolutionarily conserved.
Jendroszek A; Sønnichsen MS; Muñoz AC; Leyman K; Christensen A; Petersen SV; Wang T; Bendixen C; Panitz F; Andreasen PA; Jensen JK
Thromb Haemost; 2017 Aug; 117(9):1688-1699. PubMed ID: 28771275
[TBL] [Abstract][Full Text] [Related]
20. Distribution of the native strain in human alpha 1-antitrypsin and its association with protease inhibitor function.
Seo EJ; Im H; Maeng JS; Kim KE; Yu MH
J Biol Chem; 2000 Jun; 275(22):16904-9. PubMed ID: 10747976
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
